Tag results:
CD8
Human Immunology News
Regulation of the Antigen Presentation Machinery in Cancer and Its Implication for Immune Surveillance
[Biochemical Society Transactions] Investigators provide a comprehensive overview of physiologically conserved or novel mechanisms utilized by tumor cells to reduce MHC-I or MHC-II expression.
Immunology of Infectious Disease News
Reduced Protection of RIPK3-Deficient Mice against Influenza by Matrix Protein 2 Ectodomain Targeted Active and Passive Vaccination Strategies
[Cell Death & Disease] The authors observed that the protection against IAV after active vaccination with matrix protein 2 ectodomain viral antigen was lost was Ripk3−/− mice.
Immunology of Infectious Disease News
CD4+ T Cell Dysfunction in Severe COVID-19 Disease is TNFα/TNFRI-Dependent
[American Journal of Respiratory and Critical Care Medicine] Researchers characterized the functional SARS-CoV-2 T cell responses in severe versus recovered, mild COVID-19 patients to determine whether differences were detectable.
Human Immunology News
Tissue-Resident FOLR2+ Macrophages Associate with CD8+ T Cell Infiltration in Human Breast Cancer
[Cell] The authors identified a discrete population of FOLR2+ tissue-resident macrophages in healthy mammary gland and breast cancer primary tumors.
Immunology of Infectious Disease News
Self-Amplifying mRNA SARS-CoV-2 Vaccines Raise Cross-Reactive Immune Response to Variants and Prevent Infection in Animal Models
[Molecular Therapy-Methods & Clinical Development] Investigators showed that these self-amplifying mRNA SARS-CoV-2 vaccines raised potent neutralizing antibody responses in mice against not only the original virus but also the alpha, beta, gamma, and delta variants.
Immune Regulation News
The Pancreatic Cancer Immune Tumor Microenvironment Is Negatively Remodeled by Gemcitabine While TGF-β Receptor plus Dual Checkpoint Inhibition Maintains Antitumor Immune Cells
[Molecular Carcinogenesis] Scientists hypothesized that TGF-β receptor inhibition may alter Pancreatic ductal adenocarcinoma progression and antitumor immunity in the tumor microenvironment.